Targeted regulatory t cells to treat SLE
Ended Project Grant Awarded Last action
- Award ID
- W81XWH2210256
- Recipient
-
Monash University UEI W2VLWNVNL728
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $1,498,168
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date
- Funding
-
- $749,084.00 Federal
- $749,084.00 Non-federal
- Place of performance
- Australia
Award details come from USAspending.gov.
About this award
The Department of the Army Medical Command awarded Monash University a $1,498,168 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to support research on Targeted Regulatory T Cells to Treat SLE from September 1, 2022 through August 31, 2025. Under this award, Monash University will conduct research to investigate medical solutions for systemic lupus erythematosus (SLE) by developing targeted regulatory T cells as an innovative treatment approach. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research aimed at transforming military and public health care through impactful scientific discovery. This award will further those goals by exploring an emerging cellular immunotherapy strategy with the potential to treat SLE, a chronic autoimmune disease.
Quick answers
Who received award W81XWH2210256?
W81XWH2210256 was awarded to Monash University by Medical Command (Department of the Army) on September 1, 2022.
How much is award W81XWH2210256 worth?
$1,498,168 has been obligated on W81XWH2210256: $749,084 in federal funding and $749,084 in non-federal funding.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award